GSK buys full rights to make COVID, influenza vaccines from CureVac
Wednesday, July 3rd 2024, 6:25:52 am
article
The deal is the result of restructuring a collaboration, which began in 2020 to develop mRNA-based vaccines for infectious diseases, into a new licensing agreement, GSK added. As a result of the collaboration, the two companies have vaccine candidates for seasonal influenza and COVID-19 in phase II clinical development and avian influenza in phase I clinical development.
Breaking
Ebony Shyteria Harper, a 31-year-old standing just 4-foot-11, is trading her airplane seat for a jail cell after a disagreement turned into a fistfight at 30,000 feet....
Harris County Judge Lina Hidalgo held a brief news conference outside NRG Stadium, before she was once again escorted out of the Houston Livestock Show and Rodeo grounds....
Californian man Idress Vinay Solomon was federally charged after allegedly attacking two TSA officers and seriously injuring a Dallas police officer at Dallas Love Field Airport....
